Indoco Remedies Limited (BOM:532612)

India · Delayed Price · Currency is INR

187.60

+1.60 (0.86%)

At close: Apr 2, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals	16.65B	18.17B	16.69B	15.41B	12.42B
Pharmaceuticals Growth	-8.38%	8.91%	8.30%	24.10%	12.19%
Total	16.65B	18.17B	16.69B	15.41B	12.42B
Total Growth	-8.38%	8.91%	8.30%	24.10%	12.19%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	10.90B	9.68B	8.50B	8.47B	6.76B
India Growth	12.69%	13.86%	0.29%	25.34%	-6.85%
Outside India	5.51B	8.21B	7.90B	6.56B	5.43B
Outside India Growth	-32.87%	3.84%	20.38%	20.97%	53.15%
Total	16.41B	17.88B	16.40B	15.04B	12.19B
Total Growth	-8.22%	9.03%	9.06%	23.40%	10.12%

Source: S&P Global Market Intelligence.